Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of MLC901 (NeuroAiD Ii) in Patients With Moderate TBI: A Randomized Double Blind Placebo Controlled Trial

NCT04766281 is registered in ClinicalTrials.gov with University of the Philippines as lead sponsor.

NCT NCT04766281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04766281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of MLC901 (NeuroAiD Ii) in Patients With Moderate TBI: A Randomized Double Blind Placebo Controlled Trial
Lead sponsor
University of the Philippines
Phase
Phase 4
Overall status
Unknown status
Start date
May 1, 2021
Completion date
July 31, 2024
Enrollment
120 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

moderate traumatic brain injury